Lexology October 18, 2018
Health Care Viewpoints

Artificial intelligence—AI—is the future of everything. But when patient health is on the line, can we trust algorithms to make decisions instead of patients or their health care providers? This post, the second in our blog series about AI in health care, explores FDA’s proposed regulatory model that is supposed to be better suited for AI (and similar technologies) while still protecting patients. You can read our previous posts by clicking here.

FDA has made news recently by allowing marketing of novel technologies that incorporate AI. One device is software (yes, software can be a device) that uses AI to analyze images of the eye to make a decision about whether the patient has more than a mild level of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Technology
Hospitals Are Using AI To Help Manage Patient Messages to Physicians
ETH develops AI algorithm for drug discovery based on 3D protein surface
Space industry races to put AI in orbit
The unspoken obnoxiousness of Google’s Gemini improvements
AI bets pay off as Microsoft and Alphabet profits surge

Share This Article